Premier Alternatives

InSilico Medicine Cayman (HKG: 03696)

Biotech · Hong Kong, MA · Founded 2014 · Publicly Held

InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. InSilico Medicine Cayman (HKG: 03696) is based in Hong Kong, MA and was founded in 2014. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.7 billion (Dec 2025). It has raised $842 million across 6 recorded rounds; the latest was a $13 million Series E extension (final close) in Jun 2025.

Last price · $/share
—
Implied valuation
$1.7B
Total raised
$841.9M
Last round
Series E extension (final close)
Jun 2025
No prints on record

No secondary trades in InSilico Medicine Cayman (HKG: 03696) shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of InSilico Medicine Cayman (HKG: 03696) with a free account
  • ·The complete investor list: 50 names
  • ·Watch InSilico Medicine Cayman (HKG: 03696): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where InSilico Medicine Cayman (HKG: 03696) prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of InSilico Medicine Cayman (HKG: 03696) stock.